We have been collaborating under our Auto injector Partnership contract with the UK Ministry of Defence (MOD) over the last 2 years, where we have developed a new Nerve Agent Antidote Auto-injector. Following the sucessful manufacture and delivery of the first order to  the UK MOD we were subsequently invited to support Strategic Command, Headquarters Defence Medical Services (UK MOD) stand at DSEI exhibition 2023, where we presented our upcoming new device called MELORAI.

MELORAI is a brand new dual-chamber autoinjector developed for the UK MOD. It is the only autoinjector in the world with three active substances – Pralidoxime, Atropine and Midazolam. It should be added to our portfolio in the upcoming years.